Teva-Handok

Teva-Handok is a joint venture between Teva Pharmaceutical Industries and Handok, established in 2013 to commercialize Teva's portfolio in South Korea. The company combines Teva's global manufacturing and R&D strength with Handok's established local market presence and distribution network. Its product offerings span multiple therapeutic areas, including central nervous system (CNS) disorders, oncology, and respiratory health. Key products in its portfolio include the migraine preventive treatment Ajovy and the oncology drug Treanda. Teva-Handok continues to expand its footprint in the Korean pharmaceutical market by introducing both innovative specialty medicines and high-quality generics.